Lenacapavir, trialed in Uganda, offers 100% protection but will it reach those who need it most? Kampala, Uganda | RONALD ...

A landmark breakthrough in HIV prevention received final approval from the Food and Drug Administration last month. Gilead Sciences’ lenacapavir is so effective that global health leaders had started ...

Nurix Therapeutics shows strong BTK degrader data and key pharma ties, with risks but solid long-term potential. Find out why ...

There are over 100,000 HIV+ Texans. Trump's 'big beautiful' bill would slash funding for federal HIV prevention, medications, ...

Years of American-led investment into AIDS programs has reduced the number of people killed by the disease to the lowest ...

The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) has announced that it has signed an access agreement with Pharmaceutical Company Gilead Sciences to procure lenacapavir, a ...

Long-suffering biotech investors might be in for a treat as the SPDR S&P Biotech exchange begins to show signs of renewed strength.

President Trump signed the budget bill, but the White House now demands Congress rescind more than $9 billion — including $400 million that funds America’s international ...

The Testaments is the next Margaret Atwood book to be adapted for the small screen. It's the sequel to one of the best Hulu shows The Handmaid's Tale, so will be a continuation of the story like the ...

DAR ES SALAAM: INDIA’s Haryana State Electronics Development Corporation (HARTRON) is setting its sights on Tanzania’s ...

Discover why Vertex Pharmaceuticals outperforms amid biotech sector decline. Explore growth drivers, risks, and the ...

Every 10 minutes, an adolescent girl or young woman is infected with HIV in South Africa. But a long-acting injection could ...